ArticleLeukemia2022

Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter study.

Siddharth Kunte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.